Management of Sundowning in Dementia Patients

Non-Pharmacological Interventions

The American Academy of Sleep Medicine strongly recommends against using sleep-promoting medications due to significantly increased risks of falls, cognitive decline, confusion, and mortality that outweigh any potential benefits, and instead suggests non-pharmacological interventions as the first-line treatment for sundowning in dementia patients 1, 2, 3
Bright light therapy is the most effective and safest intervention for sundowning, using white broad-spectrum light at 2,500-5,000 lux intensity, positioned approximately 1 meter from the patient, administered for 1-2 hours daily between 9:00-11:00 AM, and continued for 4-10 weeks 1, 3
Environmental and behavioral modifications, such as maximizing daytime sunlight exposure, increasing physical and social activities during daytime hours, establishing a structured bedtime routine, reducing nighttime light and noise exposure, and removing potentially dangerous objects from the bedroom, are recommended 1, 2

The American Academy of Sleep Medicine provides a WEAK AGAINST recommendation for melatonin in elderly dementia patients with irregular sleep-wake rhythm disorder, due to low-quality evidence and potential harm, including detrimental effects on mood and daytime functioning 1, 3
Melatonin 3-6 mg at bedtime may be considered as a lowest-risk option if pharmacological intervention is absolutely necessary after non-pharmacological failure, although expectations should be modest given the lack of robust efficacy data from recent high-quality trials 1, 2
Clonazepam may be considered as second-line for REM sleep behavior disorder, but its use should be cautious due to significant risks of falls, cognitive impairment, sedation, and dependence, and the American Geriatrics Society lists it as potentially inappropriate for older adults 2, 3

Benzodiazepines, traditional hypnotics, antipsychotics, and trazodone should be avoided due to high risks of adverse effects, including falls, confusion, worsening cognitive impairment, and mortality 1, 3, 4

Never default to pharmacological treatment without first implementing comprehensive non-pharmacological interventions, and always combine medications with environmental modifications and caregiver education 1, 4
Start with the lowest possible dose and titrate slowly if medication is absolutely necessary, and monitor closely for adverse effects, particularly morning sedation, falls, and cognitive decline 2
Regularly reassess medication effectiveness and continued need, and do not continue indefinitely without evaluation 2